(MELI) MercadoLibre - Overview
Exchange: NASDAQ •
Country: Uruguay •
Currency: USD •
Type: Common Stock •
ISIN: US58733R1023
Stock:
Total Rating 32
Risk 75
Buy Signal -1.04
| Risk 5d forecast | |
|---|---|
| Volatility | 46.5% |
| Relative Tail Risk | -8.16% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.40 |
| Alpha | -36.31 |
| Character TTM | |
|---|---|
| Beta | 0.964 |
| Beta Downside | 0.967 |
| Drawdowns 3y | |
|---|---|
| Max DD | 33.39% |
| CAGR/Max DD | 0.39 |
EPS (Earnings per Share)
Revenue
Description: MELI MercadoLibre
MercadoLibre, Inc. operates online commerce platforms in Brazil, Mexico, Argentina, and internationally. The company operates Mercado Libre Marketplace, an online commerce platform that can be accessed through mobile app or website; and Mercado Pago, a financial technology solution platform, which offers comprehensive set of financial technology services to users and other users of its e-commerce platform. It also provides Mercado Fondo that allows users to invest funds deposited in their Mercado Pago accounts; Mercado Credito, which grants loans and obtains better funding alternatives; and Mercado Mercado Envios that facilitates the shipping of goods from the Company and sellers to buyers. In addition, the company provides Mercado Libre Classifieds, where users can list vehicles, properties, and services; Mercado Ads, an advertising platform, which enables retailers and brands to promote their products and services on the platform; and Mercado Shops which allows users to set-up, manage, and promote their own online webstores under a subscription-based business model. MercadoLibre, Inc. was incorporated in 1999 and is headquartered in Montevideo, Uruguay.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 2.00b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.24 > 0.02 and ΔFCF/TA -3.19 > 1.0 |
| NWC/Revenue: 17.10% < 20% (prev 17.03%; Δ 0.06% < -1%) |
| CFO/TA 0.27 > 3% & CFO 11.34b > Net Income 2.00b |
| Net Debt (7.72b) to EBITDA (3.19b): 2.42 < 3 |
| Current Ratio: 1.17 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.7m) vs 12m ago -0.00% < -2% |
| Gross Margin: 44.50% > 18% (prev 0.46%; Δ 4404 % > 0.5%) |
| Asset Turnover: 85.15% > 50% (prev 82.46%; Δ 2.69% > 0%) |
| Interest Coverage Ratio: 16.01 > 6 (EBITDA TTM 3.19b / Interest Expense TTM 148.0m) |
Altman Z'' 1.83
| A: 0.12 (Total Current Assets 33.57b - Total Current Liabilities 28.63b) / Total Assets 42.67b |
| B: 0.14 (Retained Earnings 5.81b / Total Assets 42.67b) |
| C: 0.07 (EBIT TTM 2.37b / Avg Total Assets 33.93b) |
| D: 0.15 (Book Value of Equity 5.29b / Total Liabilities 35.92b) |
| Altman-Z'' Score: 1.83 = BBB |
Beneish M -3.32
| DSRI: 0.50 (Receivables 7.26b/10.47b, Revenue 28.89b/20.78b) |
| GMI: 1.04 (GM 44.50% / 46.09%) |
| AQI: 1.05 (AQ_t 0.11 / AQ_t-1 0.10) |
| SGI: 1.39 (Revenue 28.89b / 20.78b) |
| TATA: -0.22 (NI 2.00b - CFO 11.34b) / TA 42.67b) |
| Beneish M-Score: -3.32 (Cap -4..+1) = AA |
What is the price of MELI shares?
As of March 02, 2026, the stock is trading at USD 1757.58 with a total of 787,416 shares traded.
Over the past week, the price has changed by -5.73%, over one month by -18.15%, over three months by -14.87% and over the past year by -15.11%.
Over the past week, the price has changed by -5.73%, over one month by -18.15%, over three months by -14.87% and over the past year by -15.11%.
Is MELI a buy, sell or hold?
MercadoLibre has received a consensus analysts rating of 4.40.
Therefore, it is recommended to buy MELI.
- StrongBuy: 15
- Buy: 6
- Hold: 3
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the MELI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2731.4 | 55.4% |
| Analysts Target Price | 2731.4 | 55.4% |
MELI Fundamental Data Overview February 28, 2026
P/E Trailing = 44.2522
P/E Forward = 32.2581
P/S = 3.0546
P/B = 19.9364
P/EG = 1.0413
Revenue TTM = 28.89b USD
EBIT TTM = 2.37b USD
EBITDA TTM = 3.19b USD
Long Term Debt = 4.49b USD (from longTermDebt, last quarter)
Short Term Debt = 5.05b USD (from shortTermDebt, last quarter)
Debt = 11.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.72b USD (from netDebt column, last quarter)
Enterprise Value = 93.35b USD (88.26b + Debt 11.39b - CCE 6.30b)
Interest Coverage Ratio = 16.01 (Ebit TTM 2.37b / Interest Expense TTM 148.0m)
EV/FCF = 9.24x (Enterprise Value 93.35b / FCF TTM 10.10b)
FCF Yield = 10.82% (FCF TTM 10.10b / Enterprise Value 93.35b)
FCF Margin = 34.95% (FCF TTM 10.10b / Revenue TTM 28.89b)
Net Margin = 6.91% (Net Income TTM 2.00b / Revenue TTM 28.89b)
Gross Margin = 44.50% ((Revenue TTM 28.89b - Cost of Revenue TTM 16.04b) / Revenue TTM)
Gross Margin QoQ = 43.20% (prev 43.31%)
Tobins Q-Ratio = 2.19 (Enterprise Value 93.35b / Total Assets 42.67b)
Interest Expense / Debt = 0.33% (Interest Expense 38.0m / Debt 11.39b)
Taxrate = 40.25% (225.0m / 559.0m)
NOPAT = 1.42b (EBIT 2.37b * (1 - 40.25%))
Current Ratio = 1.17 (Total Current Assets 33.57b / Total Current Liabilities 28.63b)
Debt / Equity = 1.69 (Debt 11.39b / totalStockholderEquity, last quarter 6.75b)
Debt / EBITDA = 2.42 (Net Debt 7.72b / EBITDA 3.19b)
Debt / FCF = 0.76 (Net Debt 7.72b / FCF TTM 10.10b)
Total Stockholder Equity = 5.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.89% (Net Income 2.00b / Total Assets 42.67b)
RoE = 33.73% (Net Income TTM 2.00b / Total Stockholder Equity 5.92b)
RoCE = 22.77% (EBIT 2.37b / Capital Employed (Equity 5.92b + L.T.Debt 4.49b))
RoIC = 10.49% (NOPAT 1.42b / Invested Capital 13.49b)
WACC = 8.41% (E(88.26b)/V(99.65b) * Re(9.47%) + D(11.39b)/V(99.65b) * Rd(0.33%) * (1-Tc(0.40)))
Discount Rate = 9.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.00%
[DCF] Terminal Value 79.94% ; FCFF base≈8.77b ; Y1≈10.81b ; Y5≈18.42b
[DCF] Fair Price = 5515 (EV 287.33b - Net Debt 7.72b = Equity 279.61b / Shares 50.7m; r=8.41% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 80.43 | EPS CAGR: 76.86% | SUE: -0.26 | # QB: 0
Revenue Correlation: 99.64 | Revenue CAGR: 43.72% | SUE: 0.95 | # QB: 1
EPS next Quarter (2026-06-30): EPS=13.03 | Chg7d=-1.018 | Chg30d=-0.958 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-12-31): EPS=58.02 | Chg7d=-1.828 | Chg30d=-1.586 | Revisions Net=+0 | Growth EPS=+47.3% | Growth Revenue=+30.4%
EPS next Year (2027-12-31): EPS=80.81 | Chg7d=-2.741 | Chg30d=-2.240 | Revisions Net=+3 | Growth EPS=+39.3% | Growth Revenue=+23.4%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 9.5% - Earnings Yield 2.3%)
[Growth] Growth Spread = +25.1% (Analyst 32.3% - Implied 7.2%)
P/E Forward = 32.2581
P/S = 3.0546
P/B = 19.9364
P/EG = 1.0413
Revenue TTM = 28.89b USD
EBIT TTM = 2.37b USD
EBITDA TTM = 3.19b USD
Long Term Debt = 4.49b USD (from longTermDebt, last quarter)
Short Term Debt = 5.05b USD (from shortTermDebt, last quarter)
Debt = 11.39b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.72b USD (from netDebt column, last quarter)
Enterprise Value = 93.35b USD (88.26b + Debt 11.39b - CCE 6.30b)
Interest Coverage Ratio = 16.01 (Ebit TTM 2.37b / Interest Expense TTM 148.0m)
EV/FCF = 9.24x (Enterprise Value 93.35b / FCF TTM 10.10b)
FCF Yield = 10.82% (FCF TTM 10.10b / Enterprise Value 93.35b)
FCF Margin = 34.95% (FCF TTM 10.10b / Revenue TTM 28.89b)
Net Margin = 6.91% (Net Income TTM 2.00b / Revenue TTM 28.89b)
Gross Margin = 44.50% ((Revenue TTM 28.89b - Cost of Revenue TTM 16.04b) / Revenue TTM)
Gross Margin QoQ = 43.20% (prev 43.31%)
Tobins Q-Ratio = 2.19 (Enterprise Value 93.35b / Total Assets 42.67b)
Interest Expense / Debt = 0.33% (Interest Expense 38.0m / Debt 11.39b)
Taxrate = 40.25% (225.0m / 559.0m)
NOPAT = 1.42b (EBIT 2.37b * (1 - 40.25%))
Current Ratio = 1.17 (Total Current Assets 33.57b / Total Current Liabilities 28.63b)
Debt / Equity = 1.69 (Debt 11.39b / totalStockholderEquity, last quarter 6.75b)
Debt / EBITDA = 2.42 (Net Debt 7.72b / EBITDA 3.19b)
Debt / FCF = 0.76 (Net Debt 7.72b / FCF TTM 10.10b)
Total Stockholder Equity = 5.92b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.89% (Net Income 2.00b / Total Assets 42.67b)
RoE = 33.73% (Net Income TTM 2.00b / Total Stockholder Equity 5.92b)
RoCE = 22.77% (EBIT 2.37b / Capital Employed (Equity 5.92b + L.T.Debt 4.49b))
RoIC = 10.49% (NOPAT 1.42b / Invested Capital 13.49b)
WACC = 8.41% (E(88.26b)/V(99.65b) * Re(9.47%) + D(11.39b)/V(99.65b) * Rd(0.33%) * (1-Tc(0.40)))
Discount Rate = 9.47% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.00%
[DCF] Terminal Value 79.94% ; FCFF base≈8.77b ; Y1≈10.81b ; Y5≈18.42b
[DCF] Fair Price = 5515 (EV 287.33b - Net Debt 7.72b = Equity 279.61b / Shares 50.7m; r=8.41% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 80.43 | EPS CAGR: 76.86% | SUE: -0.26 | # QB: 0
Revenue Correlation: 99.64 | Revenue CAGR: 43.72% | SUE: 0.95 | # QB: 1
EPS next Quarter (2026-06-30): EPS=13.03 | Chg7d=-1.018 | Chg30d=-0.958 | Revisions Net=+1 | Analysts=7
EPS current Year (2026-12-31): EPS=58.02 | Chg7d=-1.828 | Chg30d=-1.586 | Revisions Net=+0 | Growth EPS=+47.3% | Growth Revenue=+30.4%
EPS next Year (2027-12-31): EPS=80.81 | Chg7d=-2.741 | Chg30d=-2.240 | Revisions Net=+3 | Growth EPS=+39.3% | Growth Revenue=+23.4%
[Analyst] Revisions Ratio: +0.33 (2 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.2% (Discount Rate 9.5% - Earnings Yield 2.3%)
[Growth] Growth Spread = +25.1% (Analyst 32.3% - Implied 7.2%)